PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 12 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $57,000 | -97.7% | 5,715,000 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $2,500,000 | 0.0% | 5,715,000 | 0.0% | 0.02% | +14.3% |
Q2 2018 | $2,500,000 | 0.0% | 5,715,000 | 0.0% | 0.01% | +7.7% |
Q1 2018 | $2,500,000 | +4.8% | 5,715,000 | 0.0% | 0.01% | +18.2% |
Q4 2017 | $2,386,000 | +1.8% | 5,715,000 | 0.0% | 0.01% | -26.7% |
Q3 2017 | $2,343,000 | +40.0% | 5,715,000 | 0.0% | 0.02% | +36.4% |
Q2 2017 | $1,674,000 | +25.9% | 5,715,000 | +9.6% | 0.01% | +10.0% |
Q1 2017 | $1,330,000 | +2.6% | 5,215,000 | 0.0% | 0.01% | +42.9% |
Q4 2016 | $1,296,000 | -11.2% | 5,215,000 | 0.0% | 0.01% | -12.5% |
Q3 2016 | $1,459,000 | +27.2% | 5,215,000 | 0.0% | 0.01% | +60.0% |
Q2 2016 | $1,147,000 | – | 5,215,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 10,000,000 | $4,000,000 | 1.43% |
ARMISTICE CAPITAL, LLC | 21,760,000 | $9,161,000 | 1.08% |
Broadfin Capital, LLC | 15,000,000 | $5,983,000 | 0.88% |
Avoro Capital Advisors LLC | 6,000,000 | $2,526,000 | 0.20% |
Bruce & Co., Inc. | 2,000,000 | $800,000 | 0.18% |
Aisling Capital LLC | 2,500,000 | $1,053,000 | 0.17% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 2,000,000 | $862,000 | 0.07% |
BARINGS LLC | 7,500,000 | $3,000,000 | 0.05% |
ZAZOVE ASSOCIATES LLC | 2,000,000 | $831,000 | 0.04% |
Perceptive Advisors | 2,000,000 | $840,000 | 0.02% |